Defining and targeting health disparities in chronic obstructive pulmonary disease

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 2475-2496

  Pleasants, Roy A ^a,b   Riley, Isaretta L ^a,b   Mannino, David M ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

COPD; Health disparities; International; Interventions; Management; Prevention; Socioeconomic status

Indexed keywords

AMINOPHYLLINE; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FUEL; IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; ENVIRONMENTAL EXPOSURE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH DISPARITY; HOUSEHOLD; HUMAN; OCCUPATION; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; POLITICS; POLLUTION; PREVALENCE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTOR; SCREENING; SMOKING CESSATION; SOCIAL STATUS; TOBACCO USE; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIOECONOMICS; TREATMENT OUTCOME; VULNERABLE POPULATION;

HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; VULNERABLE POPULATIONS;

EID: 84989935144     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S79077     Document Type: Article

References (197)

1. Global Initiative for Chronic Obstructive Lung Disease. Guidelines: Summarising clinical guidelines for primary care. COPD diagnosis, management and prevention. Available from: https://www.guidelines.co.uk/gold/copd. Accessed March 8, 2016.
2. Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD. 2012;9:216-226.
3. Holloway JW, Arshad SH, Holgate ST. Using genetics to predict the natural history of asthma. J Allergy Clin Immunol. 2010;126:200-209.
4. Siedlinski M, Michael H, Cho MH, et al. Genome-wide association study of smoking behaviors in COPD patients. Thorax. 2011;66:894-902.
5. World Health Organization. Chronic obstructive pulmonary disease (COPD); Fact sheet; March 2015. Available from: https://www.who.int/mediacentre/factsheets/fs315/en/. Accessed January 23, 2016.
6. Healthy People 2020; Office of Disease Prevention and Health Promotion; US Department of Health and Human Services. Phase I Report: Recommendations for the Framework and Format of Healthy People 2020. Section IV. Advisory Committee Findings and Recommendations. Available from: https://www.healthypeople.gov/2020/about/advisory/Reports. Accessed January 23, 2016.
7. World Health Organization. The economics of social determinants of health and health inequalities: a resource book. Available from: http://apps.who.int/iris/handle/10665/84213. Accessed January 23, 2016.
8. Schraufnagel DE, Blasi F, Kraft M, et al. An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory health. Am J Respir Crit Care Med. 2013;188:865-871.
9. World Health Organization health topics-poverty. World Health Organization. Available from: http://www.who.int/topics/poverty/en/. Accessed January 23, 2016.
10. Lewis DR, Clegg LX, Johnson NJ. Lung disease mortality in the United States: the National Longitudinal Mortality Study. Int J Tuberc Lung Dis. 2009;13:1008-1014.
11. Steenland K, Hu S, Walker J. All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997. Am J Public Health. 2004;94:1037-1042.
12. Forno E, Celedon JC. Health disparities in asthma. Am J Respir Crit Care Med. 2012;185:1033-1035.
13. Crocker D, Brown C, Moolenaar R, et al. Racial and ethnic disparities in asthma medication usage and health-care utilization. Chest. 2009;136:1063-1071.
14. Pleasants R, Ohar J, Croft JB, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD. 2014;7:1-11.
15. World Health Organization. Commission on social determinants of health-final report. Closing the gap in a generation: Health equity through action on the social determinants of health. Available from: http://www.who.int/social_determinants/thecommission/finalreport/en/. Accessed January 23, 2016.
16. Whitehead M. The concepts and principles of equity and health. Health Promotion Int. 1991;6:217-228.
17. Trinder PM, Croft PR, Martyn Lewis M. Social class, smoking and the severity of respiratory symptoms in the general population. J Epidemiol Comm Health. 2000;54:340-343.
18. Shohami S, Welch A, Bingham S, et al. Area deprivation predicts lung function independently of education and social class. Eur Respir J. 2004;24:157-161.
19. Welle I, Eide GE, Gulsvik A, Bakke PS. Pulmonary gas exchange and educational level: a community study. Eur Respir J. 2004;23:583-588.
20. Schikowski T, Sugiri D, Reimann V, Pesch B, Ranft U, Kramer U. Contribution of smoking and air pollution exposure in urban areas to social differences in respiratory health. BMC Public Health. 2008;8:179.
21. Smith M, Li L, Augustyn M, Kurmi O. Prevalence and correlates of airflow obstruction in ∼317,000 never-smokers in China. Eur Respir J. 2014;44:66-77.
22. Kurmi OP, Li L, Wang J, et al. COPD and its association with smoking in the mainland China: a cross-sectional analysis of 0.5 million men and women from ten diverse areas. Int J Chron Obstruct Pulmon Dis. 2015;10:655-665.
23. Liu Y, Pleasants RA, Croft J, et al. Smoking duration, respiratory symptoms, and COPD in adults aged $45 years with a smoking history. Int J Chron Obstruc Pulmon Dis. 2015;10:1-8.
24. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax. 1991;46:863-870.
25. Eachus J, Williamw M, Chan P, et al. Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ (Clin Res). 1996;212:287-292.
26. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related factors. J Clin Epidemiol. 2000;53:755-761.
27. Marmot M, Shipley M, Brunner E, et al. Relative contribution of early life and adult socioeconomic factors to adult morbidity in the Whitehall II study. J Epidemiol Commun Health. 2001;55: 301-307.
28. Montnemery P, Bengtsson P, Elliott A, et al. Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group. Respir Med. 2001;95:744-752.
29. Lindberg A, Jonnson AC, Ronmark E, et al. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005;127:1544-1552.
30. Ellison-Loschmann L, Sunyer J, Plana E, et al. Socioeconomic status, asthma, and chronic bronchitis in a large community-based study. Eur Respir J. 2007;29:897-905.
31. Eisner MD, Blanc PD, Omachi TA, et al. Socioeconomic status, race, and COPD health outcomes. J Epidemiol Commun Health. 2011;65:26-34.
32. Halvorsen T, Matrinussen PA. The geography of chronic obstructive pulmonary disease: a population-based study of Norway. Soc Sci Med. 2014;111:25e34.
33. Karnevisto M, Vasankari T, Laitinen T, et al. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105:1140-1146.
34. Lovasi GS, Diex Roux AV, Hoffman EA, et al. Socioeconomic status is positively associated with percent emphysema on CT scan: the MESA lung study. Acad Radiol. 2011;18:199-204.
35. Yin P, Zhang M, Li Y, et al. Prevalence of COPD and its association with socioeconomic status in China: findings from China chronic disease factor surveillance 2007. BMC Public Health. 2011;11:586.
36. Herrick H, Pleasants R, Wheaton A, et al. Chronic obstructive pulmonary disease and associated health-care resource use-North Carolina 2007 and 2009. Morbid Mortal Wkly Rep. 2012;61:143-146.
37. Kainu A, Rouhos A, Sovijarvi A, et al. COPD in Helinski, Finland: socioeconomic status based on occupation has an important impact on prevalence. Scand J Public Health. 2013;41:570-578.
38. Golec M, Skorska C, Mackiewicz B, et al. Relationship between COPD and lower socioeconomic status in farmers from south-eastern Poland (Lublin region). Rural Remote Health. 2014;14:2531.
39. Hagstad S, Backman H, Anders Bjerg A, et al. Prevalence and risk factors of COPD among never-smokers in two areas of Sweden: occupational exposure to gas, dust or fumes is an important risk factor. Respir Med. 2015;109:1439e1445.
40. Lee SJ, Kim SW, Kong KA, et al. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis. 2015;10:497-506.
41. Tan WC, Sin DD, Bourbeau J, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015;70:822-829.
42. Van Rossum CT, Shipley MJ, van de Mheen H, et al. Employment grade differences in cause specific mortality. A 25 year followup of civil servants from the first Whitehall study. J Epidemiol Commun Health. 2000;54:178-184.
43. Prescott E, Godtferden N, Vestbo J, Osler M. Social position and mortality from respiratory diseases in males and females. Eur Respir J. 2003;21:821-826.
44. Huisman M, Kunst AE, Bopp M, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet. 2005;365:493-500.
45. Antonelli-Incazi R, Ancona C, Forastiere F, et al. Socioeconomic status and hospitalization in the very old: a retrospective study. BMC Public Health. 2007;7:227.
46. Blanc PD, Eisner MD, Yelin EH, et al. Socioeconomic gradients in tiotropium use among adults with COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:483-490.
47. Reilly KH, Gu D, Duan X, et al. Risk factors for chronic obstructive pulmonary disease mortality in Chinese adults. Am J Epidemiol. 2008;167:998-1004.
48. Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med. 2008;23:1757-1762.
49. Wong AWM, Gan WQG, Burns J, et al. Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J. 2008;15:361-364.
50. Arne M, Lundin F, Boman G, Janson C, Janson S, Emtner M. Factors associated with good self-rated health and quality of life in subjects with self-reported COPD. Int J Chron Obstruct Pulmon Dis. 2011;6:511-519.
51. Calderón-Larrañaga A, Carney L, Soljak M. Association of population and primary healthcare factors with hospital admission rates for chronic obstructive pulmonary disease in England: national cross-sectional study. Thorax. 2011;66:191-196.
52. Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration. 2011;82:402-408.
53. Omachi TA, Sarkar U, Yelin EH, et al. Lower health literacy is associated with poorer health status and outcomes in chronic obstructive pulmonary disease. J Gen Intern Med. 2012;28:74-81.
54. McAllister DA, Morling JR, Fischbacher CM. Socioeconomic deprivation increases the effect of winter on admissions to hospital with COPD: retrospective analysis of 10 years of national hospital data. Prim Care Res J. 2013;22:296-299.
55. Gershon AS, Hwee J, Victor JC, Wilton AS, To T. Trends in socioeconomic status-related differences in mortality among people with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11:1195-1202.
56. Lange P, Marott JL, Vestbo J, et al. Socioeconomic status and prognosis in Denmark. COPD. 2014;11:431-437.
57. Trachtenberg AJ, Dik N, Chateau D, et al. Inequities in ambulatory care and the relationship between socioeconomic status and respiratory hospitalizations: a population-based study of a Canadian city. Ann Fam Med. 2014;12:402-407.
58. Sharma G, Meena R, Goodwin J, et al. Burn injury associated with home oxygen use in patients with chronic obstructive pulmonary disease. Mayo Clin Proc. 2015;90:492-499.
59. Brown CA, Crombie AK, Tunstall-Pedoe H. Failure of cigarette smoking to explain international differences in mortality from chronic obstructive pulmonary disease. J Epidemiol Community Health. 1994;48:134-139.
60. Burney P, Jithoo, Kato B, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty-a BOLD analysis. Thorax. 2014;69:465-473.
61. Camp PG, Alejandra Ramirez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican women. Eur Respir J. 2014;43:725-734.
62. Menezes AMB, Perez-Padilla R, Roberto J, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875-1881.
63. Pleasants R, Ohar J, Croft JB, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. J Chron Obstruct Pulmon Dis. 2014;7:1-11.
64. Kosacz N, Punturieri A, Croxton TL, et al. Chronic obstructive pulmonary disease among adults-United States, 2011. Morb Mortal Wkly Rep. 2012;61:938-943.
65. Yin P, Jiang C, Cheng K, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007;370:751-757.
66. Aguku IT, King BA, Dube SR. Current cigarette smoking among adults-United States 2005-2012. MMWR Morb Mortal Wkly Rep. 2014;63:29-34.
67. Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. Br Med J Open. 2014;4:e006414.
68. Batra V, Patkar AA, Berrettini WH, et al. The genetic determinants of smoking. Chest. 2003;123:1730-1739.
69. Jaganath D, Miranda JJ, Gilman RH, et al. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res. 2015;16:40.
70. Balmes JR. Occupational contribution to the burden of chronic obstructive pulmonary disease. J Occup Environ Med. 2005;47;154-160.
71. Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J. 2003;22:462-469.
72. de Meer G, Kerkhof M, Kromhout H, Schouten JP, Heederik D. Interaction of atopy and smoking on respiratory effects of occupational dust exposure: a general population-based study. Environ Health. 2004;3:6.
73. Weinmann S, Vollmer WM, Breen V, et al. COPD and occupational exposures: a case-control study. J Occup Environ Med. 2008;50:561-569.
74. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the third National Health and Nutrition Examination Survey. Am J Epidermiol. 2002;156:738-746.
75. Mehta AJ, Miedinger D, Keidel D, et al. Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on air pollution and lung and heart diseases in adults. Am J Respir Crit Care Med. 2012;185:1292-300.
76. World Health Organization. Household air pollution and health fact sheet N°292; February 2016. Available from: http://www.who.int/mediacentre/factsheets/fs292/en/. Accessed March 15, 2016.
77. Salvi S, Barnes P. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138:3-6.
78. Torres-Duque C, Maldonado D, Perez-Padilla R, Ezzati M, Viegi G. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc. 2008;5:577-590.
79. Viegi G, Simoni M, Scognamiglio A, et al. Indoor air pollution and airway disease. Int J Tuberc Lung Dis. 2004;8:1401-1415.
80. Liu S, Zhou Y, Wang X, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax. 2007;62:889-897.
81. Orozco-Levi M, Garcia-Aymerich J, Villar J, et al. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J. 2006;27:542-546.
82. Zhang JJ, Smith KR. Household air pollution from coal and biomass fuels in China: measurements, health impacts, and interventions. Environ Health Perspect. 2007;115:848-855.
83. Zhou Y, Zou Y, Li X, et al. Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study. PLoS Med. 2014;11:e1001621.
84. Kurmi OP, Semple S, Simkhaha P, Smith WCS, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010;65:221-228.
85. Liu Y, Lee K, Perez-Padilla R, Hudson NL, Mannino DM. Outdoor and indoor air pollution and COPD-related diseases in high-and low-income countries. J Int Tuberc Lung Dis. 2012;12:115-127.
86. Sint T, Donohue JF, Ghio AJ. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. Inhal Toxicol. 2008;20:25-29.
87. Sunyer J, Schwartz J, Tobias A, Macfarlane D, Garcia J, Anto JM. Patients with chronic obstructive pulmonary disease are at increased risk of death associated with urban particle air pollution: a case-crossover analysis. Am J Epidemiol. 2000;151:50-56.
88. Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011;66:232-239.
89. Hu G, Zhou Y, Tian Y, et al. COPD from exposure to biomass fuel: a meta-analysis. Chest. 2010;138:20-31.
90. Sood A, Petersen H, Blanchette CM, et al. Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med. 2010;182:1098-1104.
91. Kim C, Chapman RS, Hu W, et al. Smoky coal, tobacco smoking, and lung cancer risk in Xunwei, China. Lung Cancer. 2014;84:31-35.
92. Boehmer TK, Foster SL, Henry JR, Woghiren-Akinnifesi EL, Yip FY. Residential proximity to major highways-United States, 2010. MMWR. 2013;62(03)[Suppl]:46-50.
93. Schultz ES, Hallberg J, Bellander T, et al. Early-life exposure to traffic-related air pollution and lung function in adolescence. Am J Respir Crit Care Med. 2016;193:171-177.
94. Schikowski T, Mills IC, Anderson HR, et al. Ambient air pollution: a cause of COPD? Eur Respir J. 2014;43:250-263.
95. Turner S, Prabhu N, Daneilan P, et al. First-and second-trimester fetal size and asthma outcomes at 10 years of age. Am J Respir Crit Care Med. 2011;184:407-413.
96. Young S, Arnott J, O’Keeffe PT, Le Souef PN, Landau LI. The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J. 2000;15:151-157.
97. Tager IB, Hanrahan JP, Tosteson TD, et al. Lung function, pre-and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis. 1993;147:811-817.
98. Håland G, Carlsen KC, Sandvik L. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med. 2006;355:1682-1689.
99. Johannessen A, Bakke PS, Hardie JA, Eagan TM. Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults. Respirology. 2012;17:499-505.
100. US Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General; 2014. Available from: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/. Accessed January 23, 2016.
101. Delpisheh A, Kelly Y, Rizwan S, Brabin BJ. Socio-economic status, smoking during pregnancy and birth outcomes: an analysis of cross-sectional community studies in Liverpool (1993-2001). J Child Health Care. 2006;10:140-148.
102. Prabhu N, Smith N, Campbell D, et al. First trimester maternal tobacco smoking habits and fetal growth. Thorax. 2010;65:235-240.
103. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005;4:7.
104. Berend N. Contribution of air pollution to COPD and small airway dysfunction. Respirology. 2016;21:10.
105. Sunyer J. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J. 2001;17:1024-1033.
106. Ko FW, Hui DS. Air pollution and chronic obstructive pulmonary disease. Respirology. 2012;17:395-401.
107. Lange P, Celli B, Agusti A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373:111-122.
108. Svanes C, Sunyer S, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010;65(1):14-20.
109. Tennant PWE, Gibson GJ, Parker L, Pearce MS. Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function. Chest. 2010;137(1):146-155.
110. de Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. 2011;183:891-897.
111. Tagiyeva N, Deveruex G, Fiedling S, et al. Outcomes of childhood asthma and wheezy bronchitis a 50-year cohort study. Am J Respir Crit Care Med. 2016;193:23-30.
112. Feinstein JS. The relationship between socioeconomic status and health; a review of the literature. Milbank Q. 1993;71:279-322.
113. Mackenbach J, Stronks K, Kunst AE. The contribution of medical care to inequalities in health. Soc Science Med. 1989;29:369-376.
114. Krishman JA. Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Arch Intern Med. 2001;161:1660-1668.
115. Gray AM. Inequalities in health. The Black Report: a summary and comment. Int J Health Serv. 1982;12:349-380.
116. Veugelers P, Yip A. Socioeconomic disparities in health care use: does universal coverage reduce inequalities in health? J Epidemiol Commun Health. 2003;57:424-428.
117. Cokkinides VE, Halpern MT, Barbeau EM, et al. Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 national health interview survey. Am J Prev Med. 2008;34: 404-412.
118. Browning KK, Ferketich AK, Salsberry PJ, et al. Socioeconomic disparity in provider-delivered assistance to quit smoking. Nicotine Tob Res. 2008;10:55-61.
119. Al-Numani D, Colucci P, Ducharme MP. Rethinking bioequivalence and equivalence requirements of orally inhaled drug products. Asian J Pharm Sci. 2015;10:461-471.
120. Montaño M, Beccerril C, Ruiz V, Ramos C, Sansores RH, González-Avila G. Matrix metalloproteinases activity in COPD associated with wood smoke. Chest. 2004;125:466-472.
121. Moran-Mendoza O, Pérez-Padilla JR, Salazar-Flores M, Vazquez-Alfaro F. Wood smoke-associated lung disease: a clinical, functional, radiological and pathological description. Int J Tuberc Lung Dis. 2008;12:1092-1098.
122. Perez-Padilla R, Ramirez-Venegas A, Sansores-Martinez R. Clinical characteristics of patients with biomass smoke-associated COPD and chronic bronchitis. J Chron Obstruct Pulm Dis. 2014;1:23-32.
123. Gonzalez-Garcia M, Tores-Duque CA, Bustos A, et al. Bronchial hyperresponsiveness in women with chronic obstructive pulmonary disease. Int J Chron Obstruc Pulmon Dis. 2012;7:367-373.
124. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med. 2006;173:393-397.
125. González-García M, Maldonado Gomez D, Torres-Duque CA, et al. Tomographic and functional findings in severe COPD: comparison between the wood smoke-related and smoking-related disease. J Bras Pneumol. 2013;39:147-154.
126. Guarnieri MJ, Diaz JV, Basu C, et al. Effects of woodsmoke exposure on airway inflammation in rural Guatemalan women. PLoS One. 2014;9:e88455.
127. Rivera RM, Cosio MG, Ghezzo H, Salazar M, Pérez-Padilla R. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis. 2008;12:972-977.
128. Aldrich MC, Munro HM, Mumma M, et al. Chronic obstructive pulmonary disease and subsequent overall and lung cancer mortality in low-income adults. PLoS One. 2015;10:e0121805.
129. Pleasants R, Herrick H, Liao W. Chronic obstructive lung disease in North Carolina: prevalence, characteristics and impact. N C Med J. 2013;74:376-383.
130. Dawkins P, Wood A, Nightingale P, Stockley R. Mortality in alpha-1-antitrypsin deficiency in the United Kingdom. Respir Med. 2009;103:1540-1547.
131. Sofianopoulou E, Rushton SP, Diggle PJ, Pless-Ulloli T. Association between respiratory prescribing, air pollution and deprivation, in primary health care. J Public Health. 2013;35:502-509.
132. Sutton W, Linn E. Where the Money Was: The Memoirs of a Bank Robber. New York: Viking Press; 1976:160.
133. Thakur N, Mcgarry ME, Oh SS, et al. The Lung Corps’ approach to reducing health disparities in respiratory disease. Ann Am Thorac Soc. 2014;11:655-660.
134. Celedón JC, Roman J, Schraufnagel DE, Thomas A. Respiratory health equality in the United States. The American Thoracic Society Perspective. Ann Am Thorac Soc. 2014;11:473-479.
135. Celli B, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir J. 2015;45:879-905.
136. Respiratory diseases of the world: Realities of today-opportunities for tomorrow. Available from: http://www.thoracic.org/global-health-firs-report-respiratory-diseases-in-the-world/index.php. Accessed January 20, 2016.
137. European COPD Coalition. Call to action on COPD. Available from: http://www.copdcoalition.eu/wp-content/uploads/2015/09/ECC-Call-to-Action-010915-BD.pdf. Accessed January 28, 2016.
138. 19th World Health Organization Model List of Essential Medicines; April 2015.
139. World Health Organization framework convention on tobacco control; 2005.
140. World Health Organization guidelines for indoor air quality: Household fuel combustion; 2014.
141. World Health Organization. 2008-2013 action plan for the global strategy for prevention and control of noncommunicable diseases.
142. World Health Organization. Prevention and control of non-communicable diseases: guidelines for primary health care in low-resource settings; 2012.
143. A global monitoring framework for noncommunicable diseases. Available from: http://www.who.int/nmh/events/2012/discussion_paper3.pdf. Accessed January 23, 2016.
144. Beran D, Zar HJ, Perrin C. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med. 2015;3:159-170.
145. Salvi S. The silent epidemic of COPD in Africa. Lancet Glob Health. 2015;3(1):e6-e7.
146. Ford ES, Croft J, Mannino DM, et al. COPD Surveillance-United States 1999-2011. Chest. 2013;144:284-305.
147. Pleasants R, Heidari K, Wheaton J, et al. Targeting chronic obstructive pulmonary disease by state-based surveillance. J Chron Obstruct Pulmon Dis. 2015;12:680-689.
148. Carré PC, Roche N, Neukirch F, et al. The effect of an information leaflet upon knowledge and awareness of COPD in potential sufferers. A randomized controlled study. Respiration. 2008;76:53-60.
149. Braido F, Baiardini I, Sumberesi M, Blasi F, Canonica GW. Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res. 2013;14:94.
150. Finn PW, Malhotra A. Health equality for pulmonary, critical care, and sleep medicine-opportunities for professional societies. Glob Heart. 2014;9:359-360.
151. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases. Institute of Medicine (US) Committee on a National Surveillance System for Cardiovascular and Select Chronic Diseases. Washington (DC): National Academies Press (US); 2011.
152. Holt J, Huston SL, Heidari K, et al. Indicators for chronic disease surveillance-United States, 2013. Morb Mortal Wkly Rep. 2015; 64(RR01):1-15.
153. Hahn EJ, Rayens MK, Adkins S, et al. Fewer hospitalizations for chronic obstructive pulmonary disease in communities with smoke-free public policies. Am J Public Health. 2014;104:1059-1065.
154. Frazer K, Callinan JE, McHugh J, et al. Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2016;2:CD005992.pub3.
155. Physician behavior and practice patterns related to smoking cessation summary report. Association of American Medical Colleges. Available from: https://www.aamc.org/download/55438/data/. Accessed January 23, 2016.
156. Haas JS, Linder JA, Park ER, et al. Proactive tobacco cessation outreach to smokers of low socioeconomic status. a randomized clinical trial. JAMA Intern Med. 2015;175:218-226.
157. Neumann T, Rasmussen M, Ghith N, et al. The Gold Standard Programme: smoking cessation interventions for disadvantaged smokers are effective in a real-life setting. Tob Control. 2013;22:e9.
158. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2:823-860.
159. United Nations Foundation Global Alliance for Clean Cookstoves and the Climate and Clean Air Coalition. Available from: http://www.unfoundation.org/what-we-do/campaigns-and-initiatives/cookstoves/. Accessed January 23, 2016.
160. Smith KR, McCracken JP, Weber MW, et al. Effect of reduction in household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled trial. Lancet. 2011;378:1717-1726.
161. Romieu I, Riojas-Rodríguez H, Marrón-Mares AT, Schilmann A, Perez-Padilla R, Masera O. Improved biomass stove intervention in rural Mexico: impact on the respiratory health of women. Am J Respir Crit Care Med. 2009;180:649-656.
162. Chapman BS, He X, Blair AE, Lan Q. Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. Br Med J. 2005;331:1050.
163. Alvis-Guzmán N, Alvis-Estrada L, Fernando de L. The cost of connecting poor households to natural gas in Colombia and its impact on health. Rev Salud Pública. 2014;14:1.
164. US Environmental Protection Agency. Standards of Performance for New Residential Wood Heaters, New Residential Hydronic Heaters and Forced-Air Furnaces. Available from: https://federalregister.gov/a/2015-03733. Accessed January 23, 2016.
165. Wang T, Niel W, Gao J, et al. Air quality during the 2008 Beijing Olympics: secondary pollutants and regional impact. Atmos Chem Phys. 2010;10:7603-7615.
166. Varkey JB, Varkey AB, Varkey B. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status. Curr Opin Pulm Med. 2009;15:90-99.
167. Bonhoeffer J, Bär G, Riffelmann M, Solèr M, Heininger U. The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection. 2005;33:13-17.
168. Damiani G, Federico B, Visca M, Agostini F, Ricciardi W. The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: a cross-sectional study. Prev Med. 2007;45:373-379.
169. Galarce EM, Minsky S, Viswanath K. Socioeconomic status, demographics, beliefs and A (H1N1) vaccine uptake in the United States. Vaccine. 2011;29:5284-5289.
170. de Lataillade C, Auvergne S, Delannoy I. 2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East. J Public Health Policy. 2009;30:83-101.
171. Report 4 of The National Chronic Obstructive Pulmonary Disease Audit 2008 Patient Survey. The Royal College of Physicians of London, British Thoracic Society and British Lung Foundation. December 2008. Available from: https://www.rcplondon.ac.uk/file/. Accessed January 23, 2016.
172. Department of Health [UK]. Chronic Obstructive Pulmonary Disease National Service Framework: Development of the national service framework for COPD; Last modified August 13, 2007. Available from: http://collection.europarchive.org/tna/20080107220102/dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/DH_4138532. Accessed January 23, 2016.
173. Lisspers K, Johansson G, Jansson C, et al. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study. Respir Med. 2014;108:1345-1354.
174. Plymouth University. FRESH AIR international research programme: Collaborating internationally to address the problem of lung disease. Available from https://www.plymouth.ac.uk/research/primarycare/fresh-air. Accessed January 23, 2016.
175. Khan MA, Ahmed M, Anil S, Walley J. Strengthening the delivery of asthma and chronic obstructive pulmonary disease care at primary health-care facilities: study design of a cluster randomized controlled trial in Pakistan. Glob Health Action. 2015;8:28225.
176. Goldstein RS, O’Hoski S. Telemedicine in COPD: time to pause. Chest. 2014;145:945-949.
177. Price D, Tinkelman DG, Nordyke RJ, Isonaka S, Halberty RJ. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129:1531-1539.
178. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). Chron Obstruct Pulmon Dis. 2008;5:85-95.
179. Hanania NA, Mannino DM, Yawn BP, et al. Predicting risk of airflow obstruction in primary care: validation of the lung function questionnaire (LFQ). Respir Med. 2010;104:1160-1170.
180. Calverley PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. Chron Obstruct Pulmon Dis. 2005;2:225-232.
181. Zhou YM, Chen SY, Tian J, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis. 2013;17:1645-1651.
182. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370:741-750.
183. Haroon S, Jordan R, Takwoingi Y, Adab P. Diagnostic accuracy of screening tests for COPD: a systematic review and meta-analysis. Br Med J Open. 2015;5(10):e008133.
184. Dirven JAM, Tange HJ, Muris JWM, et al. Early detection of COPD in general practice: patient or practice managed. A randomized controlled trial of two strategies in different socioeconomic environments. Prim Care Res. 2013;22:331-337.
185. Salpeter SS, Ormiston T, Salpeter E, Poole P, Cates C. Cardioselective beta-blockers for chronic obstructive pulmonary disease (Cochrane Review). Cochrane Database Syst Rev. 2005;4:CD003566.
186. Lammers JW, van Herwaarden CL. Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease. Br J Clin Pharmacol. 1985;20:205-210.
187. Chopra I, Chopra A, Bias TK. Reviewing risks and benefits of low-dose computed tomography screening for lung cancer. Postgrad Med. 2016;6:1-8.
188. Rall FM, Grigg-Damberger M. Roles of gender, age, race/ethnicity, and residential socioeconomics in obstructive sleep apnea syndromes. Curr Opin Pulm Med. 2012;18:568-573.
189. Marin JM, Soriano JB, Carrizo SJ, Boldava A, Celli B. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182:325-331.
190. Hill K, Mangovski-Alzamora S, Blouin M, et al. Disease-specific education in the primary care setting increases the knowledge of people with chronic obstructive pulmonary disease: a randomized controlled trial. Patient Educ Couns. 2010;81:14-18.
191. Bazargani YT, de Boer A, Leufkens H, Mantel-Teeuwisse AK. Essential medicines for COPD and asthma in low and middle income countries. Thorax. 2014;69:1149-1151.
192. Babar Z, Lessing C, Mace C, Bissell K. The availability, pricing, and affordability of three essential medicines in 52 low-and middle-income countries. Pharmacoeconomics. 2013;31:1063-1082.
193. Vestbo J, Anderson JA, Calverley PM, Celli B. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64:939-943.
194. 19th WHO Model List of Essential Medicines (April 2015). World Health Organization. Available from: http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf. Accessed January 26, 2016.
195. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
196. Beran D, Zar HJ, Perrin C, Menezes AM, Burney P. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med. 2015;3:159-170.
197. GoodRx, Inc. [homepage]. Available at: http://www.goodrx.com/. Accessed February 1, 2016.